Use of selective ep4 receptor agonists for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/41 (2006.01)

Patent

CA 2479222

The present invention is directed to methods for treating liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension, comprising administering to the patient in need thereof a therapeutically effective amount of a selective EP4 receptor agonist of formulae (I) or (II) wherein the variables A, B, Q, =U, and R2 for Formula (I); and the variables Ar, =M, =N, R, W, and Z for Formula (II) are as defined in the specification.

L'invention concerne des méthodes de traitement de l'insuffisance cardiaque, de la perte de la perméabilité du canal artériel, du glaucome ou de l'hypertension oculaire. Ces méthodes consistent à administrer à un patient ayant besoin de ce traitement une dose thérapeutiquement efficace d'un agoniste du récepteur EP¿4? sélectif représenté par la formule (I) ou (II), dans laquelle les variables A, B, Q, =U, et R?2¿ pour la formule (I); et les variables Ar, =M, =N, R, W, et Z pour la formule (II), sont telles que définies dans le descriptif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of selective ep4 receptor agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of selective ep4 receptor agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selective ep4 receptor agonists for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1889177

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.